BRIDGE TO BRAVERY SPOTLIGHT

Bridge to Bravery Spotlight

NOVEMBER 2024

Lucas' Story

When Lucas was seven, his life took an unexpected turn. After experiencing unusual symptoms a few days after recovering from Covid, Lucas required an emergency room visit. During his stay, doctors discovered that his liver enzymes were alarmingly elevated, raising concerns that led to further tests. After 12 exhausting hours in the ER and countless blood draws, Lucas was sent home with one crucial instruction: follow up with the pediatric liver department.

At that follow-up visit, more tests were conducted, and Lucas received a diagnosis that explained the abnormal findings: Alpha-1 Antitrypsin Deficiency, a rare genetic condition that affects the liver and lungs. While there is currently no cure for this condition, the diagnosis provided clarity and a way forward for Lucas and his family.

Managing a rare condition comes with challenges, but Lucas approaches life with a positive outlook and remarkable resilience.

Now, Lucas and his family are dedicated to raising awareness about Alpha-1 Antitrypsin Deficiency, hoping to inspire and support others navigating similar experiences.

Alpha-1 Antitrypsin Deficiency

Quick Facts

Alpha-1 is a genetic disorder that leads to low or undetectable levels of AAT.
May cause lung disease in adults.
May cause liver damage that gets worse over time in adults, children and infants.
Often goes undetected for years and can be misdiagnosed for asthma or COPD.
1 in every 1,500 to 3,500 people of European ancestry have Alpha-1.
While there is treatment available to slow the progression of lung disease, Alpha-1 cannot be cured without a liver transplant.

DONATE OR LEARN MORE